Home Tags Lobbying

Tag: Lobbying

Drop in political funding by MPP illustrates shift toward marijuana trade groups, MSOs

10/26/20--The Marijuana Policy Project has long been a leader in funding cannabis reform at the state and federal levels, but the current election season demonstrates that MPP’s role is shifting in a significant way – toward a more collaborative position with industry trade associations and large MJ companies. Read

Marijuana legalization proponents outraising opponents 36-to-1 in 2020

10/27/20--Financial support for marijuana legalization, both medical and recreational, has grown significantly in 2020 compared to 2016. Proponents of state ballot measures have outraised opponents this election season by almost 36-to-1, a massive increase from four years ago when advocates outstripped the opposition by only 4-to-1. Read

Pot initiative cash battle: Industry versus rich conservatives

10/22/20--The campaign to legalize recreational cannabis for adults in Arizona, Proposition 207, was recharged with nearly $1.47 million in late-summer donations, while the campaign against the initiative, Arizonans for Health and Public Safety, raised about $298,000, roughly one-fifth of the pro-cannabis side in that in the same time period. Its donations came largely from wealthy conservatives. Read

Drop in political funding by MPP illustrates shift toward marijuana trade groups, MSOs

10/26/20--Although The Marijuana Policy Project has long been a leader in funding cannabis reform at the state and federal levels, the current election season demonstrates that MPP’s role is shifting in a significant way – toward a more collaborative position with industry trade associations and large MJ companies. Read

With eye on election and beyond, marijuana industry spends millions on lobbying

10/12/20--According to an article published in Marijuana Business Daily, if Congress moves closer to passing a bill to legalize marijuana, it’s likely lobbying efforts and spending will intensify, given that a crucial question is how the federal government would regulate a national cannabis industry. Read

Federal lobbying on cannabis dipped in the first part of 2020

4/29/20--Federal lobbying expenses by cannabis and hemp organizations fell slightly during the first quarter of 2020, according to a Cannabis Wire analysis of disclosure reports. But cannabis companies have ratcheted up their efforts  in recent weeks as federal lawmakers  work to address the economic effects of the COVID-19 pandemic. Read

Opinion | Despite COVID’s threat, Polis, Hancock capitulate to the pot lobby

4/21/20--In an op-ed published in Colorado Politics, Luke Niforatos, chief of staff and senior policy adviser at Smart Approaches to Marijuana (SAM), discusses Colorado, Gov. Jared Polis decision to restrict marijuana businesses to operating on a curbside or takeout-style service only. As a result, the industry quickly revolted and Polis completely caved allowing full indoor sales to carry on as usual. It took even less time for Denver Mayor Michael Hancock to appease the influential marijuana lobby. Read

Florida: Cannabis companies spent big to lobby in 2019. What about 2020?

3/30/20--Cannabis businesses, which have increasingly turned to Florida’s rapidly growing market, spent $3.7 million on lobbying in the state in 2019—more than double the year before—according to a Cannabis Wire analysis. The trend of spending heavily on lobbying in Florida was expected to continue in 2020, but the economic damage from the coronavirus crisis is likely deep and lasting enough to seriously trim the industry’s sails. Read

Who’s spending the most to legalize marijuana

2/2/20--Major marijuana players have been spending big to influence pot policy in New York. Most are multistate companies that already have a foothold in the Empire State through medical marijuana, and would likely have a leg up in the recreational market under the current proposals. Read

Pot and public servants

11/17/19--Records released through SB32 this spring reveal a number of former lawmakers and lobbyists on the list of owners and board members of marijuana companies. Among them are two who reached speaker, the highest post in the Assembly, but had become lobbyists by the time the Legislature authorized dispensaries. The Cannabis Files features some notable names in the political realm who are leaders in the cannabis industry. Read  

The incredibly large lobbying footprint of Greenwich Biosciences

10/23/19--Greenwich Biosciences, the United States subsidiary of the British GW Pharmaceuticals, registered to lobby in every single state in the country—including ones where all forms of cannabis are prohibited—over the last three years. Greenwich has spent hundreds of thousands of dollars in 2019 alone on its state-level lobbying activities, mostly on issues related such as “scheduling of FDA approved cannabidiol drugs,” “drugs and controlled substances,” “pharmaceuticals,” “healthcare,” and “health insurance,” according to lobbying disclosures. Read

Cannabis business news you may have missed for the week ending Feb. 15

2/15/19--U.S. Congressional hearing on marijuana banking boost industry's hopes for reform, California announces the National Guard Troop will combat marijuana grows, legal marijuana sales top $6 billion in Colorado -- plus other important news from around the marijuana industry. Read